CVT Appoints Exclusive Australian Distributor.Business Editors & Health Writers EDMONTON, Alberta--(BUSINESS WIRE)--MARCH 23, 2000 CV Technologies (CDNX CDNX See Canadian Venture Exchange (CDNX). :CVQ)(CVT CVT Continuously Variable Transmission (automotive, sport, utility & hybrid vehicles) CVT Center for Victims of Torture CVT Continuing Vocational Training CVT Certified Veterinary Technician CVT Control Value Table ) announced today that it has appointed BioCeuticals, the nutritional supplement division of FIT Sales Pty. Ltd., as exclusive distributor of CVT's ChemBioPrint(TM) line of nutraceutical products to health-care providers throughout Australia. BioCeuticals intends to launch Cold-FX(R) and AD-FX(R) in April, with other ChemBioPrint(TM) products being added throughout the year. FIT Sales is a privately held, Sydney based distributor of health-care products which focus on early intervention ear·ly intervention n. Abbr. EI A process of assessment and therapy provided to children, especially those younger than age 6, to facilitate normal cognitive and emotional development and to prevent developmental disability or delay. and well-being. BioCeuticals' Technical Marketing Manager, Alex Hall Alex Hall (born Patricia Anne Thompson, 19th July 1949 in Nuneaton, Warwickshire) is a British actress and Radio presenter. Early Life Her father was a semi-professional footballer for Nuneaton FC. , stated: " We follow strict standards of sourcing only the highest quality ingredients; the addition of ChemBioPrint(TM) products will establish a new standard of excellence." According to Jim According to Jim is an American situation comedy television series originally broadcast by ABC. The show premiered with little publicity in October 2001, following the surprise hit comedy My Wife and Kids. Bruce, CVT's President & CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. : "What makes BioCeuticals a perfect fit for the introduction of CVT's ChemBioPrint(TM) products into Australia, is that they are focused on supplying health-care providers with the highest quality products and they offer customers full-service educational/technical support." Furthermore, he said, "The BioCeuticals connection strengthens our Pacific Rim distributor network with distributors in Thailand and Hong Kong." In conjunction with the ChemBioPrint(TM) product launch, BioCeuticals is sponsoring Dr. Michael Lyons upcoming tour of Australia to promote his new book, Healing the Hyperactive hy·per·ac·tive adj. 1. Highly or excessively active, as a gland. 2. Having behavior characterized by constant overactivity. 3. Afflicted with attention deficit disorder. Mind. Dr. Lyons has been an avid supporter of CVT's nutraceutical products, in particular AD-FX(R), and that support is reflected in his book and in his public lectures. Further information on BioCeuticals can be found on the FIT Internet site at www.fit.net.au. About CV Technologies CV Technologies ("CVT") is a Canadian biopharmaceutical company which has developed and commercialized proprietary technology to identify, extract, and biologically standardize natural mixtures which deliver health benefits. Located in Edmonton, Alberta, CVT has a staff of 40 people including 12 with Ph.D.'s and 2 MD's. The Company maintains two full-scale laboratories and has access to eighteen satellite facilities. Utilizing the Company's ChemBioPrint(R) technology, CVT scientists obtain specific chemical and biological profiles of natural mixtures, in addition to determining their mechanisms of action and optimal dosages. The result is the development of precise operating procedures for commercial production. All CVT products are certified effective, safe, biologically active, and consistent, batch to batch. CV Technologies markets products in Canada under its HerbTech(R) brand name and supplies proprietary ingredients to national and international markets. The Company currently holds 14 patents, which includes 8 U.S. patents. An additional 13 patents are pending, worldwide. Three Patent Cooperation Treaty The Patent Cooperation Treaty (PCT) is an international patent law treaty, concluded in 1970. It provides a unified procedure for filing patent applications to protect inventions in each of its Contracting States (see Accession section below for current membership applications have been filed. James H. Bruce, President & CEO, CV Technologies Inc. "The Canadian Venture Exchange The Canadian Venture Exchange (CDNX) is now a defunct stock exchange having been acquired by the TSX Group in 2001 and renamed the TSX Venture Exchange. History of the Canadian Venture Exchange (CDNX) has neither approved nor disapproved the information contained herein." |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion